[go: up one dir, main page]

WO2019087654A1 - Microneedle sheet and production method therefor - Google Patents

Microneedle sheet and production method therefor Download PDF

Info

Publication number
WO2019087654A1
WO2019087654A1 PCT/JP2018/036836 JP2018036836W WO2019087654A1 WO 2019087654 A1 WO2019087654 A1 WO 2019087654A1 JP 2018036836 W JP2018036836 W JP 2018036836W WO 2019087654 A1 WO2019087654 A1 WO 2019087654A1
Authority
WO
WIPO (PCT)
Prior art keywords
sheet
microneedle
raw material
main body
material liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2018/036836
Other languages
French (fr)
Japanese (ja)
Inventor
佐知 永井
依里 舟橋
夕佳 三浦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissha Co Ltd
Original Assignee
Nissha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissha Co Ltd filed Critical Nissha Co Ltd
Priority to JP2019508984A priority Critical patent/JP6576596B1/en
Priority to KR1020197036005A priority patent/KR102620136B1/en
Priority to CN201880066834.9A priority patent/CN111278499B/en
Publication of WO2019087654A1 publication Critical patent/WO2019087654A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023Drug applicators using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046Solid microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053Methods for producing microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0244Micromachined materials, e.g. made from silicon wafers, microelectromechanical systems [MEMS] or comprising nanotechnology
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00Methods of manufacture, assembly or production

Definitions

  • the present invention relates to a microneedle sheet for introducing a target substance into the horny layer of skin using a plurality of microneedles, and a method of manufacturing the same.
  • microneedles have been increasingly used, for example, in the field of medicine and in the field of beauty and health.
  • a microneedle sheet composed of a plurality of microneedles is used to administer a drug from the body surface of the human body such as skin or mucous membrane.
  • a microneedle is formed using a raw material solution in which an in-vivo soluble material such as dextran, chondroitin sulfate, hyaluronic acid and a drug are dissolved in water.
  • an in-vivo soluble material such as dextran, chondroitin sulfate, hyaluronic acid and a drug are dissolved in water.
  • a microneedle sheet in which a drug is held in a substrate having in-vivo solubility.
  • the oily component when the oily component is contained, the oily component is difficult to dissolve in water which is the solvent of the raw material liquid, and therefore the base material formed using this raw material liquid There was a possibility that unevenness occurred in the oil component in the medium, and the quality was not stable for each of a plurality of microneedles or for each lot.
  • the raw material liquid in which the oil component is emulsified is dried to form the microneedle, the emulsion balance may change in the drying process, and the oil component in the microneedle may not be uniform.
  • the present invention has been made to solve the problems as described above, and it is an object of the present invention to provide a microneedle having an oil component dispersed and held in a substrate and a method for producing the same.
  • a sheet-like main body and a plurality of microneedles formed in the sheet-like main body comprising a base having in-vivo solubility, It is a microneedle sheet containing an oil component dispersed and held in a material.
  • the oily component is uniformly held in the in-vivo soluble base material, so that microneedles of stable quality can be obtained.
  • the oily component is vanillyl butyl, oil-soluble vitamin C derivative, retinol and its derivative, astaxanthin, squalane, plant-derived component, ceramide, tocopherol, or two or more of them. It is a microneedle sheet which is a mixture.
  • the microneedles dissolve in vivo to make these components uniform in the living body. Can be introduced.
  • a third invention is a microneedle sheet containing 0.5 to 1.0% by weight of vanillyl butyl as an oil component in the constitution of the first or second invention.
  • the amount of vanillyl butyl supplied to the living body can be limited, and the necessary and sufficient efficacy of vanillyl butyl can be obtained.
  • a fourth invention is the microneedle sheet according to any one of the first to third inventions, wherein the microneedle contains 0.1 to 0.2% by weight of an emulsifier.
  • the emulsifier promotes dispersion of the oil component, so that the oil component can be more uniformly held in the microneedle.
  • a fifth invention is the microneedle sheet according to any of the first to fourth inventions, wherein the sheet-like main body is the same material as the microneedles.
  • the oily component is contained in the sheet-like main body, when the microneedle sheet is attached to the skin, the oily component to be used for cosmetic purposes from the surface of the skin by the sheet-like main body Can deliver.
  • a sixth invention is a method of manufacturing a microneedle sheet having a sheet-like main body and a plurality of microneedles formed in the sheet-like main body, wherein a biosoluble material and an oily component are added to a solvent,
  • a micro-system comprising the steps of obtaining a raw material liquid in which an oily component is emulsified, filling the raw material liquid in a mold having a plurality of recesses corresponding to the shape of the microneedle, and drying the raw material liquid filled in the mold. It is a manufacturing method of a needle.
  • the sheet-like main body and the microneedle are formed using the raw material liquid in which the in-vivo soluble material and the oily component are emulsified, and thus the sheet-like main body formed of the in-soluble substrate.
  • the oil component can be dispersed and held in the microneedle.
  • a seventh invention is a method of manufacturing a microneedle sheet having a sheet-like main body and a plurality of microneedles formed in the sheet-like main body, and adding a biodegradable material and an oil component to a solvent, A step of obtaining a raw material liquid in which an oily component is emulsified, a step of dropping the raw material liquid onto the sheet-like body, a step of bringing a pulling-up member into contact with the raw material liquid dropped onto the sheet-like body It is a manufacturing method of the microneedle sheet provided with the process of forming the raw material liquid dropped on the main body in the shape of a needle into a needle shape, and the step of drying the raw material liquid formed in the needle shape.
  • the microneedle is formed using the raw material liquid in which the in-vivo soluble material and the oil-based component are emulsified, the oil-based component is formed in the micro-needle formed of the in-vivo soluble base material. Can be distributed and held.
  • the eighth invention is the method for producing a microneedle sheet according to the sixth or seventh invention, wherein the step of obtaining the raw material liquid further adds an emulsifying agent to a solvent.
  • the emulsification of the oil component in the raw material solution is promoted by the emulsifier contained in the raw material solution, so that a microneedle sheet in which the oil component is dispersed more uniformly can be obtained.
  • FIG.1 (A) is a cross-sectional view of the microneedle sheet according to the first embodiment of the present invention
  • (b) is a cross-sectional view of the microneedle sheet according to the second embodiment of the present invention.
  • (A) to (c) is the schematic which showed the manufacturing process of the microneedle sheet
  • the microneedle sheet 10 includes a sheet-like main body 20 and a plurality of microneedles 21 on one side of the sheet-like main body 20.
  • the plurality of microneedles 21 may be regularly arranged on the sheet-like main body 20 in, for example, a lattice, a honeycomb, or a zigzag, or may be irregularly arranged.
  • the sheet-like main body 20 and the microneedles 21 are integrally configured using the same material.
  • the sheet-like main body 20 is for holding a plurality of microneedles 21.
  • the plan view shape of the sheet-like main body 20 may be a shape according to the part to be attached, and for example, when used under the eyes, it may be a curved ball shape along a line under the eyes. When used, it may be in the form of a torus in which the central portion is hollow so as to surround the periphery of the mouth. Other shapes include a rectangular shape, a polygonal shape, or a circular shape.
  • the thickness of the sheet-like main body 20 is, for example, 20 ⁇ m or more and 500 ⁇ m or less, preferably 30 ⁇ m or more so that mechanical strength of the entire sheet can be secured and it can be flexibly deformed according to the shape of the skin. It can be 100 ⁇ m or less.
  • the microneedle 21 is inserted into a living body and is for introducing a drug into the living body.
  • the shape of the microneedle 21 may be, for example, a conical shape, a truncated conical shape, or a Conyde shape.
  • the Conyde shape is a shape in which the side of a conical or frusto-conical shape is curved inward.
  • the height of the microneedles 21 (the protruding height of the microneedles 21 from the sheet-like main body 20) can be, for example, 10 ⁇ m or more and 500 ⁇ m or less, preferably 50 ⁇ m or more and 200 ⁇ m or less so that they can be inserted into a living body.
  • the density of the microneedles 21 can be, for example, 100 needles / cm 2 or more and 500 needles / cm 2 or less.
  • the sheet-like main body 20 and the microneedles 21 contain a base material 30 having in-vivo solubility and an oil component 31 dispersed and held in the base material 30 as constituent materials.
  • the sheet-like main body 20 and the microneedles 21 can be formed by drying the raw material liquid 50 containing these constituent materials in a solvent.
  • an emulsifier 32 may be contained in order to promote the dispersion of the oily component 31 in the base material 30, an emulsifier 32 may be contained.
  • other additives such as a base 30 and a stabilizer of the oil component 31 may be contained.
  • glycerol can be used, for example.
  • a solvent of the raw material liquid 50 for example, water, an organic solvent, or a mixed solvent thereof can be used.
  • hyaluronic acid chondroitin sulfate, pullulan, dextran, xanthan gum, tamarind gum, glycogen, chitin, chitosan, agarose, pectin, carboxyvinyl polymer and derivatives thereof may be used as the base material 30 having in vivo solubility. it can. In addition, these materials may be used alone or in combination of two or more.
  • the oil component 31 for example, vanillyl butyl, oil-soluble vitamin C derivative, retinol and derivatives thereof, astaxanthin, squalane, plant-derived component, ceramide, tocopherol, or a mixture of two or more of them can be used. It is preferable to use 2 or more types of mixtures containing vanillyl butyl or vanillyl butyl among these oil components 31.
  • the microneedle sheet 10 using vanillyl butyl as the oily component 31 is attached to a site using the user, the user feels a sensation of thermal sensation due to the vanillyl butyl, so the component contained in the microneedle sheet 10 is supplied to the living body It can be confirmed that a certain feeling of use can be obtained.
  • the content of vanillyl butyl in the microneedle sheet 10 is preferably 0.5 to 1.0% by weight.
  • the content of vanillyl butyl is 0.5% by weight or more, the efficacy of vanillyl butyl can be sufficiently obtained.
  • the content of vanillyl butyl is 1.0% by weight or less, the amount of vanillyl butyl can be made so strong that the effect is not too strong.
  • the emulsifier 32 can be used to promote the emulsification of the oil component 31 in the raw material liquid 50.
  • the material for example, nonionic surfactants such as disodium lauryl dilauryl glutamate can be used.
  • the content of the emulsifier 32 in the microneedle sheet 10 is preferably 0.1% by weight to 0.2% by weight. If the content of the emulsifier 32 is within this range, the microneedle sheet 10 can not be uneven, the oil component 31 can be dispersed and held, and the microneedle sheet 10 without bubbles can be formed.
  • the preparation process of the raw material liquid 50 is shown.
  • Sodium hyaluronate as the base material 30, vanillyl butyl as the oily component 31, and disodium lauryl glutamate as the emulsifier 32 are added into the solvent.
  • the solution is mixed using a homomixer to obtain the raw material liquid 50 in which the oil component 31 is emulsified.
  • a mold 80 having a plurality of recesses 81 corresponding to the shape of the microneedles 21 is prepared.
  • the raw material liquid 50 is filled in the mold 80.
  • it is dried until the raw material liquid 50 solidifies.
  • the dried microneedle sheet 10 is taken out of the mold 80 to manufacture the microneedle sheet 10 shown in FIG. 1A.
  • the microneedle sheet 10 manufactured as mentioned above uses the raw material liquid 50 which the base material 30 and the oil component 31 which are in-vivo soluble materials emulsify, and is using the sheet-like main body 20 and the microneedle 21. In order to form, it becomes the microneedle sheet 10 in which the oil component 31 is dispersed and held in the sheet-like main body 20 and the microneedles 21 formed by the base material 30 having in-vivo solubility.
  • the microneedle sheet 10 according to the second embodiment of the present invention has a base 30 with microneedles 21 having in-vivo solubility and an oil component 31 dispersed and held in the base 30.
  • the difference is that the sheet-like main body 20 and the microneedles 21 are made of different materials.
  • the sheet-like main body 20 may be the same material as the base material 30 used for the sheet-like main body 20 of the first embodiment, as long as the material is different from the microneedles 21, and another material having flexibility. May be used.
  • a material paper, a resin film, and a nonwoven fabric are mentioned, for example.
  • the raw material liquid 50 is prepared.
  • the raw material liquid 50 is dropped onto the sheet-like main body 20.
  • the raw material liquid 50 is dropped at intervals corresponding to the microneedles 21 finally obtained.
  • a cylindrical or prismatic pull-up member 60 is brought into contact with the droplets of the raw material liquid 50 dropped onto the sheet-like main body 20.
  • the lifting member 60 is pulled up to form droplets of the raw material liquid 50 in a needle shape.
  • the microneedle sheet 10 shown in FIG. 1B is manufactured by drying until the raw material liquid 50 is solidified.
  • the microneedle sheet 10 manufactured as described above is formed on the sheet-like main body 20 by using the raw material liquid 50 in which the base material 30 and the oil component 31 which are in-vivo soluble materials are emulsified.
  • the oil component 31 is dispersed and held in the microneedles 21 formed by the base material 30 having in-vivo solubility.
  • Examples 1 to 6 and Comparative Examples 1 to 8 of the microneedle sheet 10 manufactured by the manufacturing method according to the first embodiment are shown.
  • the microneedle sheet 10 of each example and comparative example uses sodium hyaluronate as the substrate 30, and 0.5 wt% or 1.0 wt% of vanillyl butyl as the oil component 31 in the substrate 30 as the emulsifier 32. It contains 0.05% by weight to 0.37% by weight of lysine sodium dilauroyl glutamate.
  • Example 1 to Example 6 and Comparative Example 1 to Comparative Example 8 the result of the appearance evaluation performed to investigate the optimum range as the content of the emulsifier 32 is shown.
  • the appearance evaluation was performed on the presence or absence of unevenness and the presence or absence of air bubbles. Unevenness in the microneedle sheet 10 is not preferable because it indicates that the oil component 31 is not dispersed. Moreover, when there are air bubbles in the microneedle sheet 10, it is not preferable in that the air bubbles impair the appearance of the product and that the microneedles 21 are not formed in the air bubbles.
  • the content of the emulsifier 32 is preferably 0.10% by weight to 0.20% by weight was obtained.
  • the content of the emulsifier 32 is preferably 0.10% by weight to 0.20% by weight.
  • the sheet-like main body 20 and the microneedles 21 are integrally formed using the same material, but when the microneedle sheet 10 is used, the oily component 31 is supplied into the living body If possible, different material is filled in a portion corresponding to the sheet-like main body 20 of the mold 80 and a portion corresponding to the micro-needle 21, and the sheet-like main body 20 and the micro needle 21 are made of different materials It is also good.
  • the microneedle sheet 10 is removed from the mold 80 in the manufacturing process of the microneedle sheet 10, but when the microneedle sheet 10 is not immediately used, the microneedle sheet 10 is used.
  • the mold 80 may be used as a protective sheet for protecting the microneedle sheet 10 without taking it out of the mold 80.
  • the raw material liquid 50 is formed into a needle shape by the pulling-up member 60
  • the microneedle 21 formed by drying the raw material liquid 50 is inserted in the living body If it is, the raw material liquid 50 may be formed into a frusto-conical shape or another shape such as a Conyde shape by the lifting member 60.
  • the droplet of the raw material liquid 50 is formed in a needle shape using the cylindrical or prismatic pulling-up member 60, but using the flat plate-like pulling-up member 60 A plurality of droplets may be simultaneously formed in a needle shape.
  • the emulsification of the raw material liquid 50 is promoted using a homomixer in order to obtain the emulsified raw material liquid 50, but in the case where the raw material liquid 50 is easily emulsified , It is not necessary to use a homomixer.
  • microneedle sheet 20 sheet-like main body 21 microneedle 30 base material 31 oil-based component 32 emulsifier 50 raw material liquid 60 pulling-up member 80 type 81 recessed part

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

The purpose of the present invention is to provide: a microneedle wherein an oil component is dispersedly held in a backing; and a production method therefor. This microneedle sheet (10) is provided with a sheetlike main body (20) and a plurality of microneedles (21) on one surface of the sheetlike main body (20). The plurality of microneedles (21) are arranged in a regular pattern such as a lattice, a honeycomb, or a houndstooth pattern on the sheetlike main body (20). The sheetlike main body (20) and the microneedle sheet (21) are integrally formed using the same material. The sheetlike main body (20) and the microneedles (21) contain, as constituent materials, a biosoluble backing (30) and an oil component (31) that is dispersedly held in the backing (30).

Description

マイクロニードルシート及びその製造方法Micro needle sheet and method of manufacturing the same

 この発明は、複数のマイクロニードルを用いて皮膚の角層に目的物質を導入するためのマイクロニードルシート及びその製造方法に関する。 The present invention relates to a microneedle sheet for introducing a target substance into the horny layer of skin using a plurality of microneedles, and a method of manufacturing the same.

 近年、マイクロニードルが例えば医療に関する分野及び美容と健康に関する分野で使用される場面が増えてきている。例えば、複数のマイクロニードルからなるマイクロニードルシートを使って、皮膚や粘膜などの人体の体表面から薬物を投与することが行われている。例えば、特開2010-94414号公報(特許文献1)には、デキストラン、コンドロイチン硫酸、ヒアルロン酸などの生体内溶解性材料と薬剤を水に溶解させた原料液を用いてマイクロニードルを形成することで、生体内溶解性を有する基材中に薬剤を保持させたマイクロニードルシートが開示されている。 In recent years, microneedles have been increasingly used, for example, in the field of medicine and in the field of beauty and health. For example, a microneedle sheet composed of a plurality of microneedles is used to administer a drug from the body surface of the human body such as skin or mucous membrane. For example, in JP-A-2010-94414 (Patent Document 1), a microneedle is formed using a raw material solution in which an in-vivo soluble material such as dextran, chondroitin sulfate, hyaluronic acid and a drug are dissolved in water. There is disclosed a microneedle sheet in which a drug is held in a substrate having in-vivo solubility.

特開2010-94414号公報JP, 2010-94414, A

 上記のような従来のマイクロニードルシート及びその製造方法では、油性成分を含有させる場合に、原料液の溶媒である水に油性成分が溶解しにくいため、この原料液を用いて形成された基材中の油性成分にムラが生じ、複数のマイクロニードル一本ごとに、あるいは、ロットごとに品質が安定しない可能性があった。又、油性成分が乳化した原料液を乾燥させ、マイクロニードルを形成する場合に、乾燥過程で乳化バランスが変化し、マイクロニードル中の油性成分が均一とならない可能性があった。 In the conventional microneedle sheet as described above and the method for producing the same, when the oily component is contained, the oily component is difficult to dissolve in water which is the solvent of the raw material liquid, and therefore the base material formed using this raw material liquid There was a possibility that unevenness occurred in the oil component in the medium, and the quality was not stable for each of a plurality of microneedles or for each lot. In addition, when the raw material liquid in which the oil component is emulsified is dried to form the microneedle, the emulsion balance may change in the drying process, and the oil component in the microneedle may not be uniform.

 この発明は、上記のような課題を解決するためになされたもので、基材中に油性成分が分散保持されたマイクロニードル及びその製造方法を提供することを目的とする。 The present invention has been made to solve the problems as described above, and it is an object of the present invention to provide a microneedle having an oil component dispersed and held in a substrate and a method for producing the same.

上記の目的を達成するために、第1の発明は、シート状本体と、シート状本体に形成された複数のマイクロニードルとを備え、マイクロニードルは、生体内溶解性を有する基材と、基材中に分散保持された油性成分とを含有するマイクロニードルシートである。 In order to achieve the above object, according to a first aspect of the present invention, there is provided a sheet-like main body and a plurality of microneedles formed in the sheet-like main body, the microneedle comprising a base having in-vivo solubility, It is a microneedle sheet containing an oil component dispersed and held in a material.

 このように構成すると、生体内溶解性を有する基材中に油性成分が均一に保持されるため、安定した品質のマイクロニードルとなる。 With such a configuration, the oily component is uniformly held in the in-vivo soluble base material, so that microneedles of stable quality can be obtained.

 第2の発明は、第1の発明において、油性成分は、バニリルブチル、油溶性ビタミンC誘導体、レチノール及びその誘導体、アスタキサンチン、スクワラン、植物由来成分、セラミド、トコフェロール、又はこれらのうちの2種以上の混合物であるマイクロニードルシートである。 In a second invention according to the first invention, the oily component is vanillyl butyl, oil-soluble vitamin C derivative, retinol and its derivative, astaxanthin, squalane, plant-derived component, ceramide, tocopherol, or two or more of them. It is a microneedle sheet which is a mixture.

 このように構成すると、生体内溶解性を有する基材中に美容目的に用いられるこれらの成分が均一に保持されるため、マイクロニードルが生体内で溶解することでこれらの成分を生体内に均一に導入することができる。 With such a configuration, since these components used for cosmetic purposes are uniformly held in the in-vivo soluble base material, the microneedles dissolve in vivo to make these components uniform in the living body. Can be introduced.

 第3の発明は、第1又は第2の発明の構成において、油性成分としてバニリルブチルを0.5から1.0重量%含有するマイクロニードルシートである。 A third invention is a microneedle sheet containing 0.5 to 1.0% by weight of vanillyl butyl as an oil component in the constitution of the first or second invention.

 このように構成すると、バニリルブチルの生体内への供給量を制限できるため、必要十分なバニリルブチルの効能を得ることができる。 With this configuration, the amount of vanillyl butyl supplied to the living body can be limited, and the necessary and sufficient efficacy of vanillyl butyl can be obtained.

 第4の発明は、第1から第3のいずれかの発明において、マイクロニードルは、乳化剤を、0.1から0.2重量%含有するマイクロニードルシートである。 A fourth invention is the microneedle sheet according to any one of the first to third inventions, wherein the microneedle contains 0.1 to 0.2% by weight of an emulsifier.

 このように構成すると、乳化剤によって、油性成分の分散が促進されるため、マイクロニードル中により均一に油性成分を保持することができる。 According to this structure, the emulsifier promotes dispersion of the oil component, so that the oil component can be more uniformly held in the microneedle.

 第5の発明は、第1から第4のいずれかの発明において、シート状本体は、マイクロニードルと同一材料であるマイクロニードルシートである。 A fifth invention is the microneedle sheet according to any of the first to fourth inventions, wherein the sheet-like main body is the same material as the microneedles.

 このように構成すると、シート状本体に油性成分が含有されるため、マイクロニードルシートを皮膚に貼り付けた場合に、シート状本体によって、肌の表面から美容目的に用いられる油性成分を肌の中まで届けることができる。 According to this structure, since the oily component is contained in the sheet-like main body, when the microneedle sheet is attached to the skin, the oily component to be used for cosmetic purposes from the surface of the skin by the sheet-like main body Can deliver.

 第6の発明は、シート状本体と、シート状本体に形成された複数のマイクロニードルとを有するマイクロニードルシートの製造方法であって、生体内溶解性材料と油性成分とを溶媒中に加え、油性成分が乳化した原料液を得る工程と、原料液をマイクロニードルの形状に対応した複数の凹部を有する型に充填する工程と、型に充填された原料液を乾燥させる工程とを備えたマイクロニードルの製造方法である。 A sixth invention is a method of manufacturing a microneedle sheet having a sheet-like main body and a plurality of microneedles formed in the sheet-like main body, wherein a biosoluble material and an oily component are added to a solvent, A micro-system comprising the steps of obtaining a raw material liquid in which an oily component is emulsified, filling the raw material liquid in a mold having a plurality of recesses corresponding to the shape of the microneedle, and drying the raw material liquid filled in the mold. It is a manufacturing method of a needle.

 このように構成すると、生体内溶解性材料と油性成分とが乳化した原料液を用いて、シート状本体及びマイクロニードルを形成するため、生体内溶解性を有する基材によって形成されるシート状本体及びマイクロニードル中に油性成分を分散保持することができる。 According to this structure, the sheet-like main body and the microneedle are formed using the raw material liquid in which the in-vivo soluble material and the oily component are emulsified, and thus the sheet-like main body formed of the in-soluble substrate. The oil component can be dispersed and held in the microneedle.

 第7の発明は、シート状本体と、シート状本体に形成された複数のマイクロニードルとを有するマイクロニードルシートの製造方法であって、生体内溶解性材料と油性成分とを溶媒中に加え、油性成分が乳化した原料液を得る工程と、原料液をシート状本体に滴下する工程と、シート状本体に滴下された原料液に引上部材を接触させる工程と、引上部材を引き上げてシート状本体に滴下された原料液を針形状に形成する工程と、針形状に形成された原料液を乾燥させる工程とを備えた、マイクロニードルシートの製造方法である。 A seventh invention is a method of manufacturing a microneedle sheet having a sheet-like main body and a plurality of microneedles formed in the sheet-like main body, and adding a biodegradable material and an oil component to a solvent, A step of obtaining a raw material liquid in which an oily component is emulsified, a step of dropping the raw material liquid onto the sheet-like body, a step of bringing a pulling-up member into contact with the raw material liquid dropped onto the sheet-like body It is a manufacturing method of the microneedle sheet provided with the process of forming the raw material liquid dropped on the main body in the shape of a needle into a needle shape, and the step of drying the raw material liquid formed in the needle shape.

 このように構成すると、生体内溶解性材料と油性成分とが乳化した原料液を用いて、マイクロニードルを形成するため、生体内溶解性を有する基材によって形成されるマイクロニードル中に、油性成分を分散保持することができる。 According to this structure, since the microneedle is formed using the raw material liquid in which the in-vivo soluble material and the oil-based component are emulsified, the oil-based component is formed in the micro-needle formed of the in-vivo soluble base material. Can be distributed and held.

 第8の発明は、第6又は第7の発明において、原料液を得る工程は、乳化剤を溶媒中にさらに加えるマイクロニードルシートの製造方法である。 The eighth invention is the method for producing a microneedle sheet according to the sixth or seventh invention, wherein the step of obtaining the raw material liquid further adds an emulsifying agent to a solvent.

 このように構成すると、原料液に含まれる乳化剤によって、原料液中の油性成分の乳化が促進されるため、より均一に油性成分が分散したマイクロニードルシートを得ることができる。 According to this structure, the emulsification of the oil component in the raw material solution is promoted by the emulsifier contained in the raw material solution, so that a microneedle sheet in which the oil component is dispersed more uniformly can be obtained.

 この発明によれば、品質を向上させた、油性成分を含むマイクロニードルシートを得ることができる。 According to this invention, it is possible to obtain a microneedle sheet containing an oily component with improved quality.

その(a)がこの発明の第1実施形態によるマイクロニードルシートの断面図であり、その(b)がこの発明の第2実施形態によるマイクロニードルシートの断面図である。(A) is a cross-sectional view of the microneedle sheet according to the first embodiment of the present invention, and (b) is a cross-sectional view of the microneedle sheet according to the second embodiment of the present invention. その(a)から(c)が図1(a)で示したマイクロニードルシートの製造工程を示した概略図である。(A) to (c) is the schematic which showed the manufacturing process of the microneedle sheet | seat shown by Fig.1 (a). その(a)から(c)が図1(b)で示したマイクロニードルシートの製造工程を示した概略図である。It is the schematic which showed the manufacturing process of the microneedle sheet which the (a) to (c) showed by FIG.1 (b).

 次に、発明の実施の形態について図を参照しながら説明する。 Next, embodiments of the invention will be described with reference to the drawings.

 図1(a)を参照して、この発明の第1実施形態によるマイクロニードルシート10は、シート状本体20とシート状本体20の一方の面に複数のマイクロニードル21を備える。複数のマイクロニードル21は、シート状本体20上に、例えば、格子状、ハニカム状、又は千鳥状に規則的に配列してもよく、又、不規則に配列してもよい。更に、シート状本体20とマイクロニードル21は同じ材料を用いて一体的に構成されている。 Referring to FIG. 1A, the microneedle sheet 10 according to the first embodiment of the present invention includes a sheet-like main body 20 and a plurality of microneedles 21 on one side of the sheet-like main body 20. The plurality of microneedles 21 may be regularly arranged on the sheet-like main body 20 in, for example, a lattice, a honeycomb, or a zigzag, or may be irregularly arranged. Furthermore, the sheet-like main body 20 and the microneedles 21 are integrally configured using the same material.

 シート状本体20は、複数のマイクロニードル21を保持するためのものである。シート状本体20の平面視形状は、貼付する部位に合わせた形状とすればよく、例えば、目の下に使用する場合には、目の下のラインに沿って湾曲した勾玉形状とすることができ、口元に使用する場合には、口の周囲を囲むように中央部が空洞となった円環形状とすることができる。その他の形状としては、矩形形状、多角形形状、又は円形状が挙げられる。又、シート状本体20の厚みは、シート全体の機械的強度が確保可能であり、かつ、皮膚の形状に応じて柔軟に変形可能なように、例えば、20μm以上500μm以下、好ましくは、30μm以上100μm以下とすることができる。 The sheet-like main body 20 is for holding a plurality of microneedles 21. The plan view shape of the sheet-like main body 20 may be a shape according to the part to be attached, and for example, when used under the eyes, it may be a curved ball shape along a line under the eyes. When used, it may be in the form of a torus in which the central portion is hollow so as to surround the periphery of the mouth. Other shapes include a rectangular shape, a polygonal shape, or a circular shape. Further, the thickness of the sheet-like main body 20 is, for example, 20 μm or more and 500 μm or less, preferably 30 μm or more so that mechanical strength of the entire sheet can be secured and it can be flexibly deformed according to the shape of the skin. It can be 100 μm or less.

 マイクロニードル21は、生体内に挿入され、生体内に薬剤を導入するためのものである。マイクロニードル21の形状は、例えば、円錐形、円錐台形、又はコニーデ形が挙げられる。尚、コニーデ形とは、円錐形又は円錐台形の側面が内向きに湾曲した形状を表す。マイクロニードル21の高さ(シート状本体20からのマイクロニードル21の突出高さ)は、生体内に挿入できるように、例えば、10μm以上500μm以下、好ましくは50μm以上200μm以下とすることができる。マイクロニードル21の密度は、例えば、100本/cm2以上500本/cm2以下とすることができる。 The microneedle 21 is inserted into a living body and is for introducing a drug into the living body. The shape of the microneedle 21 may be, for example, a conical shape, a truncated conical shape, or a Conyde shape. The Conyde shape is a shape in which the side of a conical or frusto-conical shape is curved inward. The height of the microneedles 21 (the protruding height of the microneedles 21 from the sheet-like main body 20) can be, for example, 10 μm or more and 500 μm or less, preferably 50 μm or more and 200 μm or less so that they can be inserted into a living body. The density of the microneedles 21 can be, for example, 100 needles / cm 2 or more and 500 needles / cm 2 or less.

 シート状本体20及びマイクロニードル21は、生体内溶解性を有する基材30と基材30中に分散保持された油性成分31とを構成材料として含有する。シート状本体20及びマイクロニードル21は、これらの構成材料を溶媒中に含む原料液50を乾燥させることで形成することができる。又、基材30中の油性成分31の分散を促進するために、乳化剤32を含有しても良い。さらに、基材30や油性成分31の安定化剤などのその他の添加剤を含有しても良い。安定化剤としては、例えば、グリセリンを用いることができる。 The sheet-like main body 20 and the microneedles 21 contain a base material 30 having in-vivo solubility and an oil component 31 dispersed and held in the base material 30 as constituent materials. The sheet-like main body 20 and the microneedles 21 can be formed by drying the raw material liquid 50 containing these constituent materials in a solvent. Moreover, in order to promote the dispersion of the oily component 31 in the base material 30, an emulsifier 32 may be contained. Furthermore, other additives such as a base 30 and a stabilizer of the oil component 31 may be contained. As a stabilizer, glycerol can be used, for example.

 原料液50の溶媒としては、例えば、水、有機溶媒、又はその混合溶媒を用いることができる。 As a solvent of the raw material liquid 50, for example, water, an organic solvent, or a mixed solvent thereof can be used.

 生体内溶解性を有する基材30としては、例えば、ヒアルロン酸、コンドロイチン硫酸、プルラン、デキストラン、キサンタンガム、タマリンドガム、グリコーゲン、キチン、キトサン、アガロース、ペクチン、カルボキシビニルポリマー及びこれらの誘導体を用いることができる。又、これらの材料は単独で用いてもよく、2種以上を混合して用いてもよい。 For example, hyaluronic acid, chondroitin sulfate, pullulan, dextran, xanthan gum, tamarind gum, glycogen, chitin, chitosan, agarose, pectin, carboxyvinyl polymer and derivatives thereof may be used as the base material 30 having in vivo solubility. it can. In addition, these materials may be used alone or in combination of two or more.

 油性成分31としては、例えば、バニリルブチル、油溶性ビタミンC誘導体、レチノール及びその誘導体、アスタキサンチン、スクワラン、植物由来成分、セラミド、トコフェロール、又はこれらのうちの2種以上の混合物を用いることができる。これらの油性成分31の中でも、バニリルブチル又はバニリルブチルを含む2種以上の混合物を用いることが好ましい。油性成分31としてバニリルブチルを用いたマイクロニードルシート10を使用する部位に貼り付けた場合、使用者は、バニリルブチルによって温感刺激を感じるため、マイクロニードルシート10に含有する成分が生体内に供給されたことを確認することができ、一定の使用感が得られる。又、マイクロニードルシート10中のバニリルブチルの含有量は、0.5から1.0重量%が好ましい。バニリルブチルの含有量が0.5重量%以上であれば、バニリルブチルの効能を十分に得ることができる。一方、バニリルブチルの含有量が1.0重量%以下であれば、バニリルブチルの効能が強くなりすぎない量とすることができる。 As the oil component 31, for example, vanillyl butyl, oil-soluble vitamin C derivative, retinol and derivatives thereof, astaxanthin, squalane, plant-derived component, ceramide, tocopherol, or a mixture of two or more of them can be used. It is preferable to use 2 or more types of mixtures containing vanillyl butyl or vanillyl butyl among these oil components 31. When the microneedle sheet 10 using vanillyl butyl as the oily component 31 is attached to a site using the user, the user feels a sensation of thermal sensation due to the vanillyl butyl, so the component contained in the microneedle sheet 10 is supplied to the living body It can be confirmed that a certain feeling of use can be obtained. The content of vanillyl butyl in the microneedle sheet 10 is preferably 0.5 to 1.0% by weight. When the content of vanillyl butyl is 0.5% by weight or more, the efficacy of vanillyl butyl can be sufficiently obtained. On the other hand, when the content of vanillyl butyl is 1.0% by weight or less, the amount of vanillyl butyl can be made so strong that the effect is not too strong.

 乳化剤32は、原料液50中の油性成分31の乳化を促進させるために用いることができる。材料としては、例えば、ジラウロイルグルタミン酸リシンナトリウムなどのノニオン界面活性剤を用いることができる。また、マイクロニードルシート10中の乳化剤32の含有量は、0.1重量%~0.2重量%が好ましい。乳化剤32の含有量がこの範囲内であれば、マイクロニードルシート10にムラができず、油性成分31を分散保持することができ、又、気泡のないマイクロニードルシート10を形成することができる。 The emulsifier 32 can be used to promote the emulsification of the oil component 31 in the raw material liquid 50. As the material, for example, nonionic surfactants such as disodium lauryl dilauryl glutamate can be used. Further, the content of the emulsifier 32 in the microneedle sheet 10 is preferably 0.1% by weight to 0.2% by weight. If the content of the emulsifier 32 is within this range, the microneedle sheet 10 can not be uneven, the oil component 31 can be dispersed and held, and the microneedle sheet 10 without bubbles can be formed.

 次に、図1(a)で示したマイクロニードルシート10の製造方法を示す。 Next, a method of manufacturing the microneedle sheet 10 shown in FIG. 1A will be described.

 原料液50の準備工程を示す。基材30であるヒアルロン酸ナトリウム、油性成分31であるバニリルブチル、乳化剤32であるジラウロイルグルタミン酸リシンナトリウムを溶媒中に加える。次に、ホモミキサーを用いて、溶液を混ぜ合わせることで、油性成分31が乳化した原料液50を得る。 The preparation process of the raw material liquid 50 is shown. Sodium hyaluronate as the base material 30, vanillyl butyl as the oily component 31, and disodium lauryl glutamate as the emulsifier 32 are added into the solvent. Next, the solution is mixed using a homomixer to obtain the raw material liquid 50 in which the oil component 31 is emulsified.

 次に、図2(a)を参照して、マイクロニードル21の形状に対応した複数の凹部81を有する型80を準備する。次に、図2(b)を参照して、原料液50を型80に充填する。次に、原料液50が固化するまで、乾燥させる。次に、図2(c)を参照して、型80から乾燥させたマイクロニードルシート10を取り出すことで図1(a)に示すマイクロニードルシート10の製造を行う。 Next, referring to FIG. 2A, a mold 80 having a plurality of recesses 81 corresponding to the shape of the microneedles 21 is prepared. Next, referring to FIG. 2 (b), the raw material liquid 50 is filled in the mold 80. Next, it is dried until the raw material liquid 50 solidifies. Next, referring to FIG. 2C, the dried microneedle sheet 10 is taken out of the mold 80 to manufacture the microneedle sheet 10 shown in FIG. 1A.

 以上から、上記のように製造されるマイクロニードルシート10は、生体内溶解性材料である基材30と油性成分31とが乳化した原料液50を用いて、シート状本体20及びマイクロニードル21を形成するため、生体内溶解性を有する基材30によって形成されるシート状本体20及びマイクロニードル21中に、油性成分31が分散保持されたマイクロニードルシート10となる。 As mentioned above, the microneedle sheet 10 manufactured as mentioned above uses the raw material liquid 50 which the base material 30 and the oil component 31 which are in-vivo soluble materials emulsify, and is using the sheet-like main body 20 and the microneedle 21. In order to form, it becomes the microneedle sheet 10 in which the oil component 31 is dispersed and held in the sheet-like main body 20 and the microneedles 21 formed by the base material 30 having in-vivo solubility.

 次にこの発明の第2実施形態について、図を参照しながら先の実施形態とは異なる点を中心に説明する。 Next, a second embodiment of the present invention will be described with reference to the drawings, focusing on differences from the previous embodiment.

 図1(b)を参照して、この発明の第2実施形態によるマイクロニードルシート10は、マイクロニードル21が生体内溶解性を有する基材30及び基材30中に分散保持された油性成分31によって構成されている点では、第1実施形態と同様である。一方、シート状本体20とマイクロニードル21とが別の材料によって構成されている点が異なっている。 Referring to FIG. 1 (b), the microneedle sheet 10 according to the second embodiment of the present invention has a base 30 with microneedles 21 having in-vivo solubility and an oil component 31 dispersed and held in the base 30. Are similar to the first embodiment in that they are configured by On the other hand, the difference is that the sheet-like main body 20 and the microneedles 21 are made of different materials.

 シート状本体20は、マイクロニードル21と別の材料であれば、第1実施形態のシート状本体20に用いる基材30と同様の材料を用いてもよく、又、柔軟性を有する別の材料を用いても良い。材料としては、例えば、紙類、樹脂フィルム、及び不織布が挙げられる。 The sheet-like main body 20 may be the same material as the base material 30 used for the sheet-like main body 20 of the first embodiment, as long as the material is different from the microneedles 21, and another material having flexibility. May be used. As a material, paper, a resin film, and a nonwoven fabric are mentioned, for example.

 その他の材料は、この発明の第1実施形態と同様の材料を用いることができる。 Other materials may be the same as in the first embodiment of the present invention.

 次に図1(b)で示したマイクロニードルシート10の製造方法を示す。 Next, the manufacturing method of the microneedle sheet | seat 10 shown by FIG.1 (b) is shown.

 まず、この発明の第1実施形態と同様にして、基材30であるヒアルロン酸ナトリウム、油性成分31であるバニリルブチル、乳化剤32であるジラウロイルグルタミン酸リシンナトリウムを溶媒中に含み、油性成分31が乳化した原料液50を準備する。次に、図3(a)を参照して、シート状本体20上に、原料液50を滴下する。その際、最終的に得られるマイクロニードル21に対応した間隔で原料液50を滴下する。次に、図3(b)を参照して、シート状本体20上に滴下された原料液50の液滴それぞれに対して、円柱形状又は角柱形状の引上部材60を接触させる。次に、図3(c)を参照して、引上部材60を引き上げて原料液50の液滴を針形状に形成する。次に、原料液50が固化するまで、乾燥させることで、図1(b)に示すマイクロニードルシート10の製造を行う。 First, in the same manner as in the first embodiment of the present invention, sodium hyaluronate as the base material 30, vanillyl butyl as the oil component 31, and dilauroyl glutamate sodium lysine as the emulsifier 32 are contained in the solvent, and the oil component 31 is emulsified. The raw material liquid 50 is prepared. Next, referring to FIG. 3A, the raw material liquid 50 is dropped onto the sheet-like main body 20. At that time, the raw material liquid 50 is dropped at intervals corresponding to the microneedles 21 finally obtained. Next, referring to FIG. 3B, a cylindrical or prismatic pull-up member 60 is brought into contact with the droplets of the raw material liquid 50 dropped onto the sheet-like main body 20. Next, referring to FIG. 3C, the lifting member 60 is pulled up to form droplets of the raw material liquid 50 in a needle shape. Next, the microneedle sheet 10 shown in FIG. 1B is manufactured by drying until the raw material liquid 50 is solidified.

 以上から、上記のように製造されるマイクロニードルシート10は、生体内溶解性材料である基材30と油性成分31とが乳化した原料液50を用いて、シート状本体20上にマイクロニードル21を形成するため、生体内溶解性を有する基材30によって形成されるマイクロニードル21中に、油性成分31が分散保持されたマイクロニードルシート10となる。 From the above, the microneedle sheet 10 manufactured as described above is formed on the sheet-like main body 20 by using the raw material liquid 50 in which the base material 30 and the oil component 31 which are in-vivo soluble materials are emulsified. In order to form the microneedle sheet 10, the oil component 31 is dispersed and held in the microneedles 21 formed by the base material 30 having in-vivo solubility.

 表1を参照して、第1実施形態による製造方法によって製造されるマイクロニードルシート10の実施例1~実施例6及び比較例1~比較例8を示す。各実施例及び比較例のマイクロニードルシート10は、ヒアルロン酸ナトリウムを基材30として用い、基材30中に、油性成分31としてバニリルブチルを0.5重量%又は1.0重量%、乳化剤32としてジラウロイルグルタミン酸リシンナトリウムを0.05重量%~0.37重量%含有する。 Referring to Table 1, Examples 1 to 6 and Comparative Examples 1 to 8 of the microneedle sheet 10 manufactured by the manufacturing method according to the first embodiment are shown. The microneedle sheet 10 of each example and comparative example uses sodium hyaluronate as the substrate 30, and 0.5 wt% or 1.0 wt% of vanillyl butyl as the oil component 31 in the substrate 30 as the emulsifier 32. It contains 0.05% by weight to 0.37% by weight of lysine sodium dilauroyl glutamate.

Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001

 実施例1~実施例6及び比較例1~比較例8に示すマイクロニードルシート10について、乳化剤32の含有量として最適な範囲を調べるために行った外観評価の結果を示す。外観評価は、ムラの有無及び気泡の有無について行った。マイクロニードルシート10にムラがある場合は、油性成分31が分散していないことを示すため好ましくない。又、マイクロニードルシート10に気泡がある場合は、気泡により製品の外観を損なう点、気泡がある部分にマイクロニードル21が形成されていない点で好ましくない。 About the microneedle sheet 10 shown in Example 1 to Example 6 and Comparative Example 1 to Comparative Example 8, the result of the appearance evaluation performed to investigate the optimum range as the content of the emulsifier 32 is shown. The appearance evaluation was performed on the presence or absence of unevenness and the presence or absence of air bubbles. Unevenness in the microneedle sheet 10 is not preferable because it indicates that the oil component 31 is not dispersed. Moreover, when there are air bubbles in the microneedle sheet 10, it is not preferable in that the air bubbles impair the appearance of the product and that the microneedles 21 are not formed in the air bubbles.

 まず、ムラの有無について、外観評価を行った。その結果、乳化剤32の含有量が0.08重量%~0.37重量%の範囲である実施例1~実施例6、比較例2~比較例4及び比較例6~比較例8については、ムラのないマイクロニードルシート10が得られた。一方、乳化剤32の含有量が0.05重量%である比較例1及び比較例5については、マイクロニードルシート10にムラが確認された。 First, the appearance was evaluated for the presence or absence of unevenness. As a result, for Examples 1 to 6 and Comparative Examples 2 to 4 and Comparative Examples 6 to 8 in which the content of the emulsifier 32 is in the range of 0.08% by weight to 0.37% by weight, An even microneedle sheet 10 was obtained. On the other hand, in Comparative Example 1 and Comparative Example 5 in which the content of the emulsifier 32 was 0.05% by weight, unevenness was observed in the microneedle sheet 10.

 次に、気泡の有無について、外観評価を行った。その結果、乳化剤32の含有量が0.10重量%~0.20重量%の範囲である実施例1~実施例6については、気泡のないマイクロニードルが得られた。一方、乳化剤32の含有量が0.05重量%、0.08重量%、0.30重量%、0.37重量%である比較例1~比較例8については、マイクロニードルシート10に気泡の存在が確認された。 Next, appearance evaluation was performed about the presence or absence of air bubbles. As a result, in Examples 1 to 6 in which the content of the emulsifier 32 was in the range of 0.10% by weight to 0.20% by weight, microneedles without bubbles were obtained. On the other hand, in Comparative Example 1 to Comparative Example 8 in which the content of the emulsifier 32 is 0.05% by weight, 0.08% by weight, 0.30% by weight, and 0.37% by weight, the microneedle sheet 10 contains bubbles. The existence was confirmed.

 以上から、乳化剤32の含有量としては、0.10重量%~0.20重量%が好ましいという結果が得られた。乳化剤32の含有量をこの範囲内とすることで、ムラ及び気泡のないマイクロニードルシート10を得ることができる。 From the above, the result that the content of the emulsifier 32 is preferably 0.10% by weight to 0.20% by weight was obtained. By setting the content of the emulsifier 32 within this range, it is possible to obtain the microneedle sheet 10 without unevenness and bubbles.

 尚、この発明の第1実施形態では、シート状本体20とマイクロニードル21を同じ材料を用いて一体的に構成したが、マイクロニードルシート10を使用した場合に、生体内に油性成分31を供給することが可能であれば、型80のシート状本体20に対応する部分とマイクロニードル21に対応する部分に異なる材料を充填し、シート状本体20とマイクロニードル21を別の材料で構成してもよい。 In the first embodiment of the present invention, the sheet-like main body 20 and the microneedles 21 are integrally formed using the same material, but when the microneedle sheet 10 is used, the oily component 31 is supplied into the living body If possible, different material is filled in a portion corresponding to the sheet-like main body 20 of the mold 80 and a portion corresponding to the micro-needle 21, and the sheet-like main body 20 and the micro needle 21 are made of different materials It is also good.

 又、この発明の第1実施形態では、マイクロニードルシート10の製造工程において、マイクロニードルシート10を型80から取り出したが、すぐにマイクロニードルシート10を使用しない場合には、マイクロニードルシート10を型80から取り出さずに、型80をマイクロニードルシート10を保護する保護シートとして用いてもよい。 In the first embodiment of the present invention, the microneedle sheet 10 is removed from the mold 80 in the manufacturing process of the microneedle sheet 10, but when the microneedle sheet 10 is not immediately used, the microneedle sheet 10 is used. The mold 80 may be used as a protective sheet for protecting the microneedle sheet 10 without taking it out of the mold 80.

 更に、この発明の第2実施形態では、引上部材60によって原料液50を針形状に形成したが、原料液50を乾燥することで形成されるマイクロニードル21が生体内に挿入される形状であれば、引上部材60によって原料液50を円錐台形、又はコニーデ形などのその他の形状に形成してもよい。 Furthermore, in the second embodiment of the present invention, although the raw material liquid 50 is formed into a needle shape by the pulling-up member 60, the microneedle 21 formed by drying the raw material liquid 50 is inserted in the living body If it is, the raw material liquid 50 may be formed into a frusto-conical shape or another shape such as a Conyde shape by the lifting member 60.

 更に、この発明の第2実施形態では、円柱形状又は角柱形状の引上部材60を用いて、原料液50の液滴を針形状に形成したが、平板状の引上部材60を用いて、複数の液滴を同時に針形状に形成してもよい。 Furthermore, in the second embodiment of the present invention, the droplet of the raw material liquid 50 is formed in a needle shape using the cylindrical or prismatic pulling-up member 60, but using the flat plate-like pulling-up member 60 A plurality of droplets may be simultaneously formed in a needle shape.

 更に、この発明の上記の各実施形態では、乳化した原料液50を得るために、ホモミキサーを用いて、原料液50の乳化を促進させたが、原料液50が容易に乳化する場合には、ホモミキサーを用いなくてもよい。 Furthermore, in the above embodiments of the present invention, the emulsification of the raw material liquid 50 is promoted using a homomixer in order to obtain the emulsified raw material liquid 50, but in the case where the raw material liquid 50 is easily emulsified , It is not necessary to use a homomixer.

 10 マイクロニードルシート
 20 シート状本体
 21 マイクロニードル
 30 基材
 31 油性成分
 32 乳化剤
50 原料液
 60 引上部材
 80 型
 81 凹部
DESCRIPTION OF SYMBOLS 10 microneedle sheet 20 sheet-like main body 21 microneedle 30 base material 31 oil-based component 32 emulsifier 50 raw material liquid 60 pulling-up member 80 type 81 recessed part

Claims (8)

シート状本体と、
前記シート状本体に形成された複数のマイクロニードルとを備え、
前記マイクロニードルは、生体内溶解性を有する基材と、前記基材中に分散保持された油性成分とを含有するマイクロニードルシート。
Sheet-like body,
And a plurality of microneedles formed on the sheet-like body,
The microneedle is a microneedle sheet containing a substrate having in-vivo solubility and an oily component dispersed and held in the substrate.
 前記油性成分は、バニリルブチル、油溶性ビタミンC誘導体、レチノール及びその誘導体、アスタキサンチン、スクワラン、植物由来成分、セラミド、トコフェロール、又はこれらのうちの2種以上の混合物である、請求項1に記載のマイクロニードルシート。 The microparticle according to claim 1, wherein the oily component is vanillyl butyl, an oil-soluble vitamin C derivative, retinol and a derivative thereof, astaxanthin, squalane, a plant-derived component, ceramide, tocopherol, or a mixture of two or more thereof. Needle seat.  前記油性成分としてバニリルブチルを0.5から1.0重量%含有する、請求項1又は請求項2に記載のマイクロニードルシート。 The microneedle sheet according to claim 1 or 2, wherein 0.5 to 1.0% by weight of vanillyl butyl is contained as the oily component.  前記マイクロニードルは、乳化剤を、0.1から0.2重量%含有する、請求項1から請求項3のいずれかに記載のマイクロニードルシート。 The microneedle sheet according to any one of claims 1 to 3, wherein the microneedle contains an emulsifier at 0.1 to 0.2% by weight.  前記シート状本体は、前記マイクロニードルと同一材料である、請求項1から請求項4のいずれかに記載のマイクロニードルシート。 The microneedle sheet according to any one of claims 1 to 4, wherein the sheet-like main body is the same material as the microneedles.  シート状本体と、前記シート状本体に形成された複数のマイクロニードルとを有するマイクロニードルシートの製造方法であって、
 生体内溶解性材料と油性成分とを溶媒中に加え、油性成分が乳化した原料液を得る工程と、
 前記原料液を前記マイクロニードルの形状に対応した複数の凹部を有する型に充填する工程と、
 前記型に充填された前記原料液を乾燥させる工程とを備えたマイクロニードルの製造方法。
A method of manufacturing a microneedle sheet, comprising: a sheet-like main body; and a plurality of microneedles formed on the sheet-like main body,
Adding a bio-soluble material and an oily component to a solvent to obtain a raw material liquid in which the oily component is emulsified;
Filling the raw material liquid in a mold having a plurality of recesses corresponding to the shape of the microneedles;
And d) drying the raw material liquid filled in the mold.
 シート状本体と、前記シート状本体に形成された複数のマイクロニードルとを有するマイクロニードルシートの製造方法であって、
 生体内溶解性材料と油性成分とを溶媒中に加え、油性成分が乳化した原料液を得る工程と、
 前記原料液を前記シート状本体に滴下する工程と、
 前記シート状本体に滴下された前記原料液に引上部材を接触させる工程と、
 前記引上部材を引き上げて前記シート状本体に滴下された前記原料液を針形状に形成する工程と、
 針形状に形成された前記原料液を乾燥させる工程とを備えた、マイクロニードルシートの製造方法。
A method of manufacturing a microneedle sheet, comprising: a sheet-like main body; and a plurality of microneedles formed on the sheet-like main body,
Adding a bio-soluble material and an oily component to a solvent to obtain a raw material liquid in which the oily component is emulsified;
Dropping the raw material solution onto the sheet-like body;
Bringing a pull-up member into contact with the raw material liquid dropped onto the sheet-like main body;
Forming the needle-shaped raw material liquid dropped into the sheet-like main body by pulling up the pulling-up member;
And d) drying the raw material liquid formed into a needle shape.
 前記原料液を得る工程は、乳化剤を溶媒中にさらに加える、請求項6又は請求項7に記載のマイクロニードルシートの製造方法。 The method for producing a microneedle sheet according to claim 6 or 7, wherein the step of obtaining the raw material liquid further adds an emulsifier into a solvent.
PCT/JP2018/036836 2017-11-02 2018-10-02 Microneedle sheet and production method therefor Ceased WO2019087654A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2019508984A JP6576596B1 (en) 2017-11-02 2018-10-02 Microneedle sheet and manufacturing method thereof
KR1020197036005A KR102620136B1 (en) 2017-11-02 2018-10-02 Microneedle sheet and manufacturing method thereof
CN201880066834.9A CN111278499B (en) 2017-11-02 2018-10-02 Microneedle sheet and method for producing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017212704 2017-11-02
JP2017-212704 2017-11-02

Publications (1)

Publication Number Publication Date
WO2019087654A1 true WO2019087654A1 (en) 2019-05-09

Family

ID=66333523

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/036836 Ceased WO2019087654A1 (en) 2017-11-02 2018-10-02 Microneedle sheet and production method therefor

Country Status (4)

Country Link
JP (1) JP6576596B1 (en)
KR (1) KR102620136B1 (en)
CN (1) CN111278499B (en)
WO (1) WO2019087654A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7235352B1 (en) 2021-09-29 2023-03-08 ラファス カンパニー リミテッド Composition for manufacturing microneedle patch to be applied to lips and microneedle patch manufactured with this composition
JP2023136623A (en) * 2022-03-17 2023-09-29 凸版印刷株式会社 Transplanting device, and method for manufacturing the same

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114681354A (en) * 2020-12-31 2022-07-01 苏州悦肤达医疗科技有限公司 Microneedle patch and preparation method thereof
KR102769473B1 (en) * 2022-01-19 2025-02-19 에스엔텔 주식회사 Microneedle containing oil and method for manufacturing the same

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007045783A (en) * 2005-08-11 2007-02-22 Naomoto Kogyo Kk Method for improving percutaneous absorptivity of external skin agent, and cosmetic method
JP2008542387A (en) * 2005-05-31 2008-11-27 タカサゴ インターナショナル コーポレーション (ユーエスエー) Topical warming composition
US20110240201A1 (en) * 2010-04-01 2011-10-06 Nurim Wellness Co., Ltd. Method of manufacturing microstructure
JP2012504160A (en) * 2008-10-01 2012-02-16 ヌリ−エム ウェルネス カンパニー リミテッド Solid microstructure capable of controlling multiple drug release and manufacturing method thereof
JP2012097108A (en) * 2011-12-28 2012-05-24 Asahi Kasei Chemicals Corp External preparation
JP2016175852A (en) * 2015-03-19 2016-10-06 ライオン株式会社 Manufacturing method of microneedle pharmaceutical preparation
WO2017175650A1 (en) * 2016-04-07 2017-10-12 日本写真印刷株式会社 Microneedle sheet

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010094414A (en) 2008-10-20 2010-04-30 Kyokko Seiko Co Ltd Microneedle sheet patch, and method and apparatus for manufacturing the same
GB201107642D0 (en) * 2011-05-09 2011-06-22 Univ Cork Method
KR101574760B1 (en) * 2013-11-13 2015-12-04 주식회사 엘지생활건강 Microneedle system having improved absorbing rate of active ingredients
KR102560154B1 (en) * 2015-05-13 2023-07-26 주식회사 엘지생활건강 Soluble Microneedle patch for vitamin E and vitamin derivative delivery
CN105213251B (en) * 2015-09-22 2017-11-07 拉芳家化股份有限公司 A kind of anticreep shampoo with thermal sensation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008542387A (en) * 2005-05-31 2008-11-27 タカサゴ インターナショナル コーポレーション (ユーエスエー) Topical warming composition
JP2007045783A (en) * 2005-08-11 2007-02-22 Naomoto Kogyo Kk Method for improving percutaneous absorptivity of external skin agent, and cosmetic method
JP2012504160A (en) * 2008-10-01 2012-02-16 ヌリ−エム ウェルネス カンパニー リミテッド Solid microstructure capable of controlling multiple drug release and manufacturing method thereof
US20110240201A1 (en) * 2010-04-01 2011-10-06 Nurim Wellness Co., Ltd. Method of manufacturing microstructure
JP2012097108A (en) * 2011-12-28 2012-05-24 Asahi Kasei Chemicals Corp External preparation
JP2016175852A (en) * 2015-03-19 2016-10-06 ライオン株式会社 Manufacturing method of microneedle pharmaceutical preparation
WO2017175650A1 (en) * 2016-04-07 2017-10-12 日本写真印刷株式会社 Microneedle sheet

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7235352B1 (en) 2021-09-29 2023-03-08 ラファス カンパニー リミテッド Composition for manufacturing microneedle patch to be applied to lips and microneedle patch manufactured with this composition
JP2023049658A (en) * 2021-09-29 2023-04-10 ラファス カンパニー リミテッド Composition for manufacturing microneedle patch to be applied to lips and microneedle patch manufactured with this composition
JP2023136623A (en) * 2022-03-17 2023-09-29 凸版印刷株式会社 Transplanting device, and method for manufacturing the same

Also Published As

Publication number Publication date
JPWO2019087654A1 (en) 2019-11-14
KR102620136B1 (en) 2024-01-02
CN111278499B (en) 2022-06-24
JP6576596B1 (en) 2019-09-18
KR20200084303A (en) 2020-07-10
CN111278499A (en) 2020-06-12

Similar Documents

Publication Publication Date Title
Alkilani et al. Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems
Tucak et al. Microneedles: Characteristics, materials, production methods and commercial development
WO2019087654A1 (en) Microneedle sheet and production method therefor
JP6481613B2 (en) Microneedle and method for manufacturing microneedle
Procopio et al. Recent fabrication methods to produce polymer-based drug delivery matrices (experimental and in silico approaches)
Angelova et al. Liquid crystalline nanostructures as pegylated reservoirs of omega-3 polyunsaturated fatty acids: Structural insights toward delivery formulations against neurodegenerative disorders
US11801371B2 (en) Microneedle device
JP6369026B2 (en) Microneedle and method for manufacturing microneedle
WO2011002034A1 (en) Needle-like material
Chen et al. High internal phase emulsions synergistically stabilized by sodium carboxymethyl cellulose and palm kernel oil ethoxylates as an essential oil delivery system
CN108998847A (en) A kind of preparation method of active nano inclusion enclave electrospun fibers film cloth
JPWO2017018086A1 (en) Micro needle seat
KR20180046290A (en) Maskpack or Patch with microneedle
JP6173616B2 (en) Microneedle sheet and manufacturing method thereof
JP2017095427A (en) Dissolution type microneedle pharmaceutical preparation
JP6023752B2 (en) Microneedle sheet and patch for transdermal administration
JP2016189845A (en) Microneedle sheet
JP7020399B2 (en) Transdermal administration device
US20200230033A1 (en) Micro-spicule composition to control its shape and method for producing the same
TWI809028B (en) Microneedle sheet and manufacturing method thereof
JP2019006798A (en) Acicular body
JP6369991B2 (en) Method for producing microneedle preparation
JP2015016160A (en) Micro needle
TWI892898B (en) Mictoneedle patch, and soluble film and transdermal absoprtion composition thereof
JP2018135286A (en) Uneven structure, percutaneous administration device, and percutaneous administration device set

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2019508984

Country of ref document: JP

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18874025

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18874025

Country of ref document: EP

Kind code of ref document: A1